CLINICAL_TRIALS
trial_result
· 2016-08-19
Clinical Trial Update: Intranasal Fentanyl for Initial Treatment of a Vaso-occlusive Crisis [Phase 4]
Summary
A Phase 4 clinical trial evaluated intranasal fentanyl as initial treatment for vaso-occlusive crisis in sickle cell disease. The study is completed and results…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Montefiore Medical Center | Conditions: Anemia, Sickle Cell, Pain | Phase 4 | Status: COMPLETED | Results posted: 2016-08-19